HERON THERAPEUTICS, INC. /DE/ Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2012 to Q1 2024.
  • Heron Therapeutics, Inc. /De/ Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $11K.
  • Heron Therapeutics, Inc. /De/ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $54.1M, a 27.9% decline from 2022.
  • Heron Therapeutics, Inc. /De/ annual Net Cash Provided by (Used in) Financing Activities for 2022 was $75.1M, a 51.9% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Net Cash Provided by (Used in) Financing Activities for 2021 was $156M, a 1614% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $11K* +$219K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 -$208K +$429K +67.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 -$637K -$1.52M -172% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $883K +$376K +74.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $507K -$6.03M -92.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $6.54M +$2.54M +63.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $4M -$162M -97.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $166M +$163M +6445% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $2.53M -$348K -12.1% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-05
Q1 2015 $2.88M +$1.92M +200% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q1 2014 $958K +$346K +56.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q1 2013 $612K +$612K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.